Kathleen Goetz insider trades
Open-market stock purchases and sales by Kathleen Goetz, Director at Aurinia Pharmaceuticals Inc, from SEC Form 4 filings since Jan 26, 2022.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +9%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | AUPH Aurinia Pharmaceuticals Inc | Bought (not open market) | — |
Companies traded
- AUPH Aurinia Pharmaceuticals Inc: other filings, last Jun 4, 2026
- HQH abrdn HealthCare Investors: 3 buys, last Apr 9, 2024
- THQ abrdn HealthCare Opportunities Fund: 3 buys, last Apr 9, 2024
- THW abrdn World HealthCare Fund: 3 buys, last Apr 9, 2024
- HQL abrdn Life Sciences Investors: 3 buys, last Apr 9, 2024